Meningitis cluster linked to University of Kent prompts mass antibiotics drive as two die

On a damp March morning in Canterbury, the line outside the University of Kent’s Senate building stretched past the glass atrium and down towards the bus stops. Hundreds of students waited in near silence, scrolling their phones and clutching campus ID cards, to receive a single antibiotic tablet meant to protect them from a disease that can kill in hours.

By the end of the weekend, 13 young people linked to the university and the wider Canterbury area had been diagnosed with invasive meningococcal disease, commonly described as meningitis. Eleven were reported to be seriously ill in hospital. Two had died — one a University of Kent student, the other a sixth-form pupil at Queen Elizabeth’s Grammar School in Faversham.

Health officials say the numbers are small in absolute terms but serious for a single community, and they warn that the infection can escalate quickly.

“Meningococcal disease can progress rapidly, so it’s essential that students and staff are alert to the signs and symptoms of meningococcal meningitis and septicaemia,” Dr. Trish Mannes, deputy director for the UK Health Security Agency (UKHSA) in the South East, said in a statement.

The outbreak, first made public on March 15, has triggered one of the largest campus-based prophylaxis operations in recent years and sharpened questions about how well Britain protects its students from a disease that continues to stalk teenagers and young adults.

Large-scale response as campus stays open

UKHSA said it has identified 13 cases of invasive meningococcal disease associated with the Canterbury area and is arranging antibiotics for some students. The agency is contacting more than 30,000 students, staff and family members to inform them of the situation and identify those who should receive preventive treatment.

Specialist teams are interviewing families and close contacts of those who have fallen ill to map where the bacteria may have spread. As of March 16, officials said the exact strain, or serogroup, of meningococcus involved in the outbreak had not yet been confirmed in public laboratory reports.

The University of Kent confirmed that one of the people who died was enrolled at the university.

“We are deeply saddened that one of our students has died,” a university spokesperson said. “Our thoughts are with the student’s family, friends and the wider university community at this extremely difficult time. The safety of our students and staff remains our highest priority.”

University leaders said they are working closely with public health teams and that campuses will remain open, with teaching and exams continuing as planned. That position has unsettled some students and parents, who associate serious infectious disease outbreaks with the shutdowns and remote teaching that defined the COVID-19 pandemic.

How meningococcal disease strikes

Invasive meningococcal disease is caused by the bacterium Neisseria meningitidis. Many people carry the organism harmlessly in their nose or throat, but in some cases it enters the bloodstream or the fluid surrounding the brain and spinal cord, causing meningitis, septicaemia, or both.

Even with prompt hospital care, the infection can be fatal in about 5% to 10% of cases. Survivors may face long-term complications, including hearing loss, neurological problems or limb loss.

Typical symptoms include:

• high fever
• severe headache
• stiff neck
• vomiting
• joint and muscle pain
• confusion
• extreme sleepiness
• sensitivity to bright light

A blotchy rash that does not fade under pressure — the so-called glass tumbler test — can appear later in the illness, especially in cases of blood poisoning.

Health officials warn that early signs can be easily mistaken for a bad cold, flu or a hangover, a particular concern on a university campus.

“Students are particularly at risk of missing the early warning signs of meningitis because they can be easily confused with other illnesses,” Mannes said.

Tom Nutt, chief executive of the charity Meningitis Now, said the disease “can progress very quickly” and have a “devastating” impact on families.

“We know that teenagers and young adults, particularly those who are starting university and living closely with lots of new people, are a key risk group,” he said, urging students to seek urgent medical help if they feel seriously unwell.

Why universities are vulnerable

Meningococcal bacteria spread through respiratory droplets and close, prolonged contact — kissing, sharing drinks or cutlery, or living in close quarters. Research in the United Kingdom and elsewhere has long shown that first-year university students living in halls of residence have higher rates of meningococcal disease than their peers of the same age who do not attend university or who live at home.

The University of Kent’s main campus in Canterbury fits a classic high-risk profile: large residential colleges and halls; shared kitchens and bathrooms; and a busy local nightlife. Students posting online said antibiotic clinics on campus were initially focused on residents of certain blocks and people identified as close contacts or attendees at specific social events, in line with national guidance.

UKHSA has not confirmed any particular venue as the source of spread. A popular nightclub in Canterbury has issued its own precautionary statement, saying people with meningitis may have visited, but health authorities have not publicly named it or linked the outbreak to a single location.

Vaccines and gaps in protection

The outbreak has drawn renewed attention to the country’s meningococcal vaccination strategy for young people.

Several strains of meningococcus circulate in the U.K., grouped into serogroups such as A, B, C, W and Y. A vaccine known as MenACWY, which protects against four of these types, is offered free to teenagers in school years 9 or 10 and to first-year university students up to age 25. That program has driven cases caused by serogroup C to very low levels.

By contrast, serogroup B (MenB) has become the most frequent cause of invasive meningococcal disease in children and young adults in England. A MenB vaccine was added to the routine childhood immunization schedule in 2015, but it is not offered as a universal, free vaccine to older teenagers and university students; those outside the infant program who want MenB protection typically must pay privately.

That leaves a cohort gap. Most current university students were born before the MenB infant rollout and may not have had that jab. Some also missed their chance to receive MenACWY at school due to disruptions and hesitancy during the COVID-19 pandemic.

Health officials have not said publicly which serogroup is involved in the Kent outbreak. Under UKHSA guidance, the decision to offer a targeted vaccination campaign in an educational setting depends on laboratory confirmation of the strain and an assessment of the pattern of cases.

Charities and some infectious disease specialists have previously called on government advisers to revisit the cost-effectiveness calculations that led to MenB not being routinely offered to adolescents. They argue that recurring fatal cases in teenagers and university students show that a high-risk group remains under-protected.

Rising cases after the pandemic

The outbreak on the Kent campus is unfolding against a backdrop of meningococcal disease numbers that have climbed back up after an artificial low during the COVID-19 years. Social distancing and lockdowns sharply reduced the spread of many respiratory infections, including meningococcus, but also interrupted some school-based vaccination programs.

Recent surveillance data for England show several hundred laboratory-confirmed cases of invasive meningococcal disease annually, with infants and young adults aged 15 to 24 the most affected groups. Meningitis Now has warned that cases are on the rise again and urged renewed awareness among teenagers and university students.

For now, public health agencies are focused on containing the cluster in Canterbury and Faversham and urging anyone in the area who feels seriously unwell to seek urgent medical care.

“We understand that many people at the university and in the wider community will be affected by this sad news and we would like to offer our condolences to the friends and family involved,” Mannes said.

Back outside the Senate building, the queues for antibiotics moved slowly forward. Some students walked straight to the library afterward, determined not to fall behind in exam preparations. Others headed back to their rooms, refreshing email and news sites for updates.

The immediate goal, for doctors and students alike, is to prevent more names being added to the list of those seriously ill. Longer term, the cluster is likely to fuel a wider debate over how the U.K. should use the vaccines and tools it already has to protect young people living, studying and socialising in close quarters.